While the 32A9-CAR-T cells eliminated the tumor cells in vitro and encouraged the regression of HCC xenograft tumors in vivo, it was shown that the antibody-immunotoxin complex was exclusively lethal to GPC3-positive tumor cells [25]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.